Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs.
Politique ou Programme
Santé, Industrie, Recherche et développement, Sciences et technologies
Engagement with officials on the development of the Canada's Drug Agency and Bill C-64: An Act respecting pharmacare
Proposition législative, Projet de loi ou résolution, Politique ou Programme
Santé, Industrie, Recherche et développement, Sciences et technologies
Establish Innovation, Science and Economic Development Canada policies related to research and development of treatments for rare disorders
Politique ou Programme
Santé
Regulatory amendments to the Food and Drugs Act Regulations to implement an orphan drug regulatory framework
Règlement
Budget, Santé, Industrie, Recherche et développement, Sciences et technologies
Scientific Research and Experimental Development Tax Incentive Program as it pertains to research and development of treatments for rare disorders
Politique ou Programme
Budget, Santé, Industrie
Share perspectives of the rare disorders patient community on drug pricing issues, specifically regulations and guidelines related to the Patented Medicine Prices Review Board.